Study 200195 App Application icon

Study 200195 App 2.29.98

33.7 MB / 1+ Downloads / Rating 5.0 - 1 reviews


See previous versions

Study 200195 App, developed and published by GSK, has released its latest version, 2.29.98, on 2018-04-24. This app falls under the Medical category on the Google Play Store and has achieved over 100 installs. It currently holds an overall rating of 5.0, based on 1 reviews.

Study 200195 App APK available on this page is compatible with all Android devices that meet the required specifications (Android 4.4+). It can also be installed on PC and Mac using an Android emulator such as Bluestacks, LDPlayer, and others.

Read More

App Screenshot

App Screenshot

App Details

Package name: com.clinical6.study200195

Updated: 7 years ago

Developer Name: GSK

Category: Medical

App Permissions: Show more

Installation Instructions

This article outlines two straightforward methods for installing Study 200195 App on PC Windows and Mac.

Using BlueStacks

  1. Download the APK/XAPK file from this page.
  2. Install BlueStacks by visiting http://bluestacks.com.
  3. Open the APK/XAPK file by double-clicking it. This action will launch BlueStacks and begin the application's installation. If the APK file does not automatically open with BlueStacks, right-click on it and select 'Open with...', then navigate to BlueStacks. Alternatively, you can drag-and-drop the APK file onto the BlueStacks home screen.
  4. Wait a few seconds for the installation to complete. Once done, the installed app will appear on the BlueStacks home screen. Click its icon to start using the application.

Using LDPlayer

  1. Download and install LDPlayer from https://www.ldplayer.net.
  2. Drag the APK/XAPK file directly into LDPlayer.

If you have any questions, please don't hesitate to contact us.

Previous Versions

Study 200195 App 2.29.98
2018-04-24 / 33.7 MB / Android 4.4+

About this app

Study 200195 App’s purpose is to support GSK Study 200195 (Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Registry for Patients Treated with Strimvelis™ (or GSK269273) Gene Therapy: Long-Term Prospective, Non-Interventional Follow-up of Safety and Effectiveness). Registry participant’s will be able to use the app to enter the required information for the study.

App Permissions

Allows applications to open network sockets.
Allows an application to initiate a phone call without going through the Dialer user interface for the user to confirm the call.
Allows using PowerManager WakeLocks to keep processor from sleeping or screen from dimming.
Allows an application to write to external storage.
Allows an application to read from external storage.